361 related articles for article (PubMed ID: 33280442)
1. Immunological mechanisms underlying sterile inflammation in the pathogenesis of atherosclerosis: potential sites for intervention.
Truong R; Thankam FG; Agrawal DK
Expert Rev Clin Immunol; 2021 Jan; 17(1):37-50. PubMed ID: 33280442
[No Abstract] [Full Text] [Related]
2. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in THP-1 cells in a stage-specific manner: An underlying role of innate immunity in atherosclerosis.
Mehta S; Dhawan V
Cell Signal; 2020 Aug; 72():109645. PubMed ID: 32305666
[TBL] [Abstract][Full Text] [Related]
3. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
Shirasuna K; Karasawa T; Takahashi M
J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
[TBL] [Abstract][Full Text] [Related]
4. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Martínez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
7. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis.
Zhang L; Yuan M; Zhang L; Wu B; Sun X
Biochem Biophys Res Commun; 2019 Jun; 514(1):266-272. PubMed ID: 31030940
[TBL] [Abstract][Full Text] [Related]
10. Role of NLRP3 Inflammasomes in Atherosclerosis.
Karasawa T; Takahashi M
J Atheroscler Thromb; 2017 May; 24(5):443-451. PubMed ID: 28260724
[TBL] [Abstract][Full Text] [Related]
11. Role of the NLRP3 Inflammasome in Preeclampsia.
Shirasuna K; Karasawa T; Takahashi M
Front Endocrinol (Lausanne); 2020; 11():80. PubMed ID: 32161574
[TBL] [Abstract][Full Text] [Related]
12. Inflammasome Priming in Sterile Inflammatory Disease.
Patel MN; Carroll RG; Galván-Peña S; Mills EL; Olden R; Triantafilou M; Wolf AI; Bryant CE; Triantafilou K; Masters SL
Trends Mol Med; 2017 Feb; 23(2):165-180. PubMed ID: 28109721
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers.
Gouravani M; Khalili N; Razi S; Keshavarz-Fathi M; Khalili N; Rezaei N
Expert Rev Clin Immunol; 2020 Feb; 16(2):175-187. PubMed ID: 31928260
[No Abstract] [Full Text] [Related]
14. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome pathways in atherosclerosis.
Baldrighi M; Mallat Z; Li X
Atherosclerosis; 2017 Dec; 267():127-138. PubMed ID: 29126031
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
18. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome as a New Therapeutic Target for Diabetic Complications.
Volpe CM; Anjos PM; Nogueira-Machado JA
Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852
[TBL] [Abstract][Full Text] [Related]
20. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
An N; Gao Y; Si Z; Zhang H; Wang L; Tian C; Yuan M; Yang X; Li X; Shang H; Xiong X; Xing Y
Front Immunol; 2019; 10():1592. PubMed ID: 31354731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
